Multiple Myeloma News

Filter by type:
Filter by category:
Filter by year:

Comparison of serum free light chain and urine electrophoresis for the detection of the light chain...

Dejoie T, Attal M, Moreau P, Harousseau JL, Avet-Loiseau H. Haematologica. 2015 Dec 3. pii: haematol.2015.126797. [Epub ahead of print] PMID: 26635032...

FOXM1 is a therapeutic target for high-risk multiple myeloma.

Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S. Leukemia. 2015 Dec 9. doi: 10.1038/leu.2015.334....

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or...

Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C,...

Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple...

Richardson PG, Jagannath S, Moreau P, Jakubowiak AJ, Raab MS, Facon T, Vij R, White D, Reece DE, Benboubker L, Zonder J, Tsao LC, Anderson KC, Bleickardt E,...

Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma...

Harshman SW, Canella A, Ciarlariello PD, Agarwal K, Branson OE, Rocci A, Cordero H, Phelps MA, Hade EM, Dubovsky JA, Palumbo A, Rosko A, Byrd JC, Hofmeister...

Page 10 of 16« First...89101112...Last »